Search results for: 'part growth captur'

22 Jun 2020  |  North America  |  Technology Research

Analysing Sepsis Management Part I: Diagnosis

Recent Advances in Sepsis Diagnosis: PCR, Immunoassays, Sequencing and beyond

Infographics

×

Sepsis diagnosis The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms...

The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 a...

Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

Emerging endoscopy technologies leverage advanced surgical visualization and instrumentation techniques during the pre-operative and intraoperative phases of surgical procedures. The use of these techniques helps surgeons to clearly visualize, accurately identify, and localize anomalies, and subsequently navigate and perform complex surgeries with ...

The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

26 Aug 2024  |  Global  |  Market Research

Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024 2029

Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth

Infographics

×

The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development. According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040,...

31 Aug 2020  |    |  Technology Research

Data Science Impacting the Pharmaceutical Industry Part II: Clinical trial Applications

Enabling faster analysis using advanced tools

Infographics

×

Clinical Trials, the most crucial step in drug discovery has never been in the forefront in adopting new technologies and transforming from the conventional protocols. With the development of AI/ML in the last five years, it has opened up a new horizon for transforming clinical trials. It has been proven that use of AI/ML tools can scan through la...